New CVD Risk Factors for Lowered Cognitive Functioning
2 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
To explore the associations between cognitive functioning and three major cardiovascular disease risk factors: high blood pressure; high total plasma homocysteine (tHcy); and ApoE e4 genotype.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2001
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2001
CompletedFirst Submitted
Initial submission to the registry
May 16, 2002
CompletedFirst Posted
Study publicly available on registry
May 17, 2002
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2007
CompletedJuly 29, 2016
January 1, 2008
5.9 years
May 16, 2002
July 28, 2016
Conditions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Related Publications (1)
Elias PK, Elias MF, Robbins MA, Budge MM. Blood pressure-related cognitive decline: does age make a difference? Hypertension. 2004 Nov;44(5):631-6. doi: 10.1161/01.HYP.0000145858.07252.99. Epub 2004 Oct 4.
PMID: 15466661BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
Merrill Elias
University of Maine
Study Design
- Study Type
- observational
- Sponsor Type
- NIH
Study Record Dates
First Submitted
May 16, 2002
First Posted
May 17, 2002
Study Start
April 1, 2001
Primary Completion
March 1, 2007
Study Completion
March 1, 2007
Last Updated
July 29, 2016
Record last verified: 2008-01